Sõda

MEEDIAVALVUR: algab „sõjalise erioperatsiooni“ teine etapp nimega „SÕDA“

Joel Habener is a Professor of Medicine at Harvard Medical School and an Associate Physician at the Massachusetts General Hospital.[1]

Early life and education

Habener graduated with a BS degree Cum Laude from the University of Redlands in 1960. He received his MD in 1965 from the University of California School of Medicine.[2]

Career

Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited.[3] Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[4] He was elected to the National Academy of Sciences in 2020.[5] In 2021, he was awarded the Canada Gairdner International Award.[6] In 2023, he received the VinFuture Prize.[7] In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research,[8] the Tang Prize in the category of "Biopharmaceutical Science",[9] the Lasker Award for clinical research[10][11] and also in 2024 the BBVA Foundation Frontiers of Knowledge Award in the category "Biology and Biomedicine".[12]

References


Kommenteeri